Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Brundage RC"" wg kryterium: Autor


Wyświetlanie 1-18 z 18
Tytuł:
Pharmacodynamic characterization of gemcitabine cytotoxicity in an in vitro cell culture bioreactor system.
Autorzy:
Kirstein MN
Brundage RC
Moore MM
Williams BW
Hillman LA
Dagit JW
Fisher JE
Marker PH
Kratzke RA
Yee D
Kirstein, Mark N
Brundage, Richard C
Moore, Megan M
Williams, Brent W
Hillman, Lisa A
Dagit, Jason W
Fisher, James E
Marker, Paul H
Kratzke, Robert A
Yee, Douglas
Pokaż więcej
Źródło:
Cancer Chemotherapy & Pharmacology; Feb2008, Vol. 61 Issue 2, p291-299, 9p
Czasopismo naukowe
Tytuł:
A pharmacokinetic simulation study to assess the performance of a sparse blood sampling approach to quantify early drug exposure.
Autorzy:
Sathe AG; Department of Experimental and Clinical Pharmacology, College of Pharmacy, Minneapolis, Minnesota, USA.
Brundage RC; Department of Experimental and Clinical Pharmacology, College of Pharmacy, Minneapolis, Minnesota, USA.
Ivaturi V; Center for Translational Medicine, University of Maryland, College Park, Maryland, USA.
Cloyd JC; Department of Experimental and Clinical Pharmacology, College of Pharmacy, Minneapolis, Minnesota, USA.
Chamberlain JM; Division of Emergency Medicine, Children's National Hospital, Washington, DC, USA.
Elm JJ; Department of Public Health Science, Medical University of South Carolina, Charleston, South Carolina, USA.
Silbergleit R; Department of Emergency Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Kapur J; Department of Neurology and Department of Neuroscience, Brain Institute, University of Virginia, Charlottesville, Virginia, USA.
Coles LD; Department of Experimental and Clinical Pharmacology, College of Pharmacy, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2021 Jul; Vol. 14 (4), pp. 1444-1451. Date of Electronic Publication: 2021 May 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Models, Biological*
Blood Specimen Collection/*methods
Drug Monitoring/*methods
Adolescent ; Adult ; Area Under Curve ; Biological Variation, Population ; Child ; Child, Preschool ; Computer Simulation ; Emergency Treatment ; Female ; Healthy Volunteers ; Humans ; Levetiracetam/administration & dosage ; Levetiracetam/blood ; Levetiracetam/pharmacokinetics ; Male ; Middle Aged ; Phenytoin/administration & dosage ; Phenytoin/blood ; Phenytoin/pharmacokinetics ; Valproic Acid/administration & dosage ; Valproic Acid/blood ; Valproic Acid/pharmacokinetics ; Young Adult
Czasopismo naukowe
Tytuł:
Application of Deep Neural Networks as a Prescreening Tool to Assign Individualized Absorption Models in Pharmacokinetic Analysis.
Autorzy:
Jaber MM; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Yaman B; Department of Electrical and Computer Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
Sarafoglou K; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55454, USA.
Brundage RC; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2021 May 26; Vol. 13 (6). Date of Electronic Publication: 2021 May 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Evaluation of bias in weighted residual calculations when handling below the limit of quantification data using Beal's M3 method.
Autorzy:
Jaber MM; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Cheng S; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Brundage RC; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2021 Apr; Vol. 10 (4), pp. 275-278.
Typ publikacji:
Address; Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Computer Simulation/*statistics & numerical data
Data Science/*statistics & numerical data
Research Design/*statistics & numerical data
Bias ; Evaluation Studies as Topic ; Humans ; Models, Theoretical ; Pharmacokinetics ; Radiotherapy Planning, Computer-Assisted
Czasopismo naukowe
Tytuł:
Individualized Absorption Models in Population Pharmacokinetic Analyses.
Autorzy:
Jaber MM; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Al-Kofahi M; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Sarafoglou K; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.; Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.
Brundage RC; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2020 Jun; Vol. 9 (6), pp. 307-309. Date of Electronic Publication: 2020 May 21.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Gastrointestinal Absorption*
Models, Biological*
Adrenal Hyperplasia, Congenital/*drug therapy
Hydrocortisone/*pharmacokinetics
Administration, Oral ; Adrenal Hyperplasia, Congenital/blood ; Humans ; Hydrocortisone/administration & dosage ; Hydrocortisone/blood
Czasopismo naukowe
Tytuł:
A hierarchical Bayesian approach for combining pharmacokinetic/pharmacodynamic modeling and Phase IIa trial design in orphan drugs: Treating adrenoleukodystrophy with Lorenzo's oil.
Autorzy:
Basu C; a Division of Biostatistics , School of Public Health, University of Minnesota , Minneapolis , Minnesota , USA.
Ahmed MA; b Experimental and Clinical Pharmacology, College of Pharmacy , University of Minnesota , Minneapolis , Minnesota , USA.; c College of Pharmacy , Helwan University , Helwan , Egypt.
Kartha RV; d Center for Orphan Drug Research, College of Pharmacy , University of Minnesota , Minneapolis , Minnesota , USA.
Brundage RC; b Experimental and Clinical Pharmacology, College of Pharmacy , University of Minnesota , Minneapolis , Minnesota , USA.
Raymond GV; e Department of Neurology , University of Minnesota Medical School , Minneapolis , Minnesota , USA.
Cloyd JC; d Center for Orphan Drug Research, College of Pharmacy , University of Minnesota , Minneapolis , Minnesota , USA.
Carlin BP; a Division of Biostatistics , School of Public Health, University of Minnesota , Minneapolis , Minnesota , USA.
Pokaż więcej
Źródło:
Journal of biopharmaceutical statistics [J Biopharm Stat] 2016; Vol. 26 (6), pp. 1025-1039. Date of Electronic Publication: 2016 Aug 22.
Typ publikacji:
Journal Article
MeSH Terms:
Bayes Theorem*
Clinical Trials, Phase II as Topic*
Research Design*
Adrenoleukodystrophy/*drug therapy
Erucic Acids/*pharmacokinetics
Triolein/*pharmacokinetics
Dose-Response Relationship, Drug ; Drug Combinations ; Erucic Acids/blood ; Erucic Acids/therapeutic use ; Humans ; Male ; Orphan Drug Production ; Triolein/therapeutic use
Czasopismo naukowe
Tytuł:
SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours.
Autorzy:
Khatri A; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA.
Williams BW; 1] Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [2] Clinical Pharmacology Shared Resource of Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55414, USA.
Fisher J; 1] Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [2] Clinical Pharmacology Shared Resource of Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55414, USA.
Brundage RC; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA.
Gurvich VJ; 1] Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [2] Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [3] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Lis LG; Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA.
Skubitz KM; 1] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [2] Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Dudek AZ; 1] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [2] Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Greeno EW; 1] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [2] Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Kratzke RA; 1] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [2] Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Lamba JK; 1] Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [2] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [3] PUMA-Institute of Personalized Medicine, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Kirstein MN; 1] Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [2] Clinical Pharmacology Shared Resource of Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55414, USA [3] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [4] PUMA-Institute of Personalized Medicine, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2014 Jan 21; Vol. 110 (2), pp. 304-12. Date of Electronic Publication: 2013 Dec 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antimetabolites, Antineoplastic/*administration & dosage
Antimetabolites, Antineoplastic/*pharmacokinetics
Deoxycytidine/*analogs & derivatives
Membrane Transport Proteins/*genetics
Neoplasms/*genetics
Neoplasms/*metabolism
5'-Nucleotidase/genetics ; 5'-Nucleotidase/metabolism ; Adult ; Aged ; Aged, 80 and over ; Alleles ; Antimetabolites, Antineoplastic/blood ; Cytidine Deaminase/genetics ; Cytidine Deaminase/metabolism ; Deoxycytidine/administration & dosage ; Deoxycytidine/blood ; Deoxycytidine/pharmacokinetics ; Female ; Genotype ; Humans ; Infusions, Intravenous ; Leukocytes, Mononuclear/metabolism ; Male ; Membrane Transport Proteins/metabolism ; Middle Aged ; Neoplasms/blood ; Neoplasms/drug therapy ; Young Adult ; Gemcitabine
Czasopismo naukowe
Tytuł:
Population pharmacokinetics of rifampicin in Mexican patients with tuberculosis.
Autorzy:
Milán Segovia RC; Doctorado en Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana, México. />Domínguez Ramírez AM
Jung Cook H
Magaña Aquino M
Vigna Pérez M
Brundage RC
Romano Moreno S
Pokaż więcej
Źródło:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2013 Feb; Vol. 38 (1), pp. 56-61. Date of Electronic Publication: 2012 Nov 20.
Typ publikacji:
Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms:
Models, Biological*
Antibiotics, Antitubercular/*pharmacokinetics
Rifampin/*pharmacokinetics
Tuberculosis/*drug therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibiotics, Antitubercular/administration & dosage ; Antibiotics, Antitubercular/therapeutic use ; Biological Availability ; Female ; Humans ; Male ; Mexico ; Middle Aged ; Nonlinear Dynamics ; Prospective Studies ; Rifampin/administration & dosage ; Rifampin/therapeutic use ; Sex Factors ; Tissue Distribution ; Young Adult
Czasopismo naukowe
Tytuł:
Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder.
Autorzy:
Holman CJ; Department of Laboratory Medicine and Pathology, University of Minnesota Medical Center, Minneapolis, MN 55455, USA.
Karger AB
Mullan BD
Brundage RC
Balfour HH Jr
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2012 Sep-Oct; Vol. 26 (5), pp. 741-7. Date of Electronic Publication: 2012 Mar 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Postoperative Complications*
Virus Shedding*
Epstein-Barr Virus Infections/*virology
Lymphoproliferative Disorders/*diagnosis
Organ Transplantation/*adverse effects
Adult ; Child ; DNA, Viral/genetics ; Epstein-Barr Virus Infections/complications ; Epstein-Barr Virus Infections/genetics ; Female ; Follow-Up Studies ; Herpesvirus 4, Human/genetics ; Herpesvirus 4, Human/pathogenicity ; Humans ; Lymphoproliferative Disorders/etiology ; Male ; Polymerase Chain Reaction ; Prognosis ; Viral Load
Czasopismo naukowe
    Wyświetlanie 1-18 z 18

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies